Bulletin
Investor Alert

Nov. 22, 2021, 7:54 a.m. EST

DGAP-News: Deciphera Receives European Commission Approval of QINLOCK(R) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor

DGAP-News: Deciphera Pharmaceuticals, Inc. / Key word(s): Regulatory Approval
Deciphera Receives European Commission Approval of QINLOCK(R) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor

22.11.2021 / 13:52
The issuer is solely responsible for the content of this announcement.

1250978 22.11.2021

COMTEX_397436375/2560/2021-11-22T07:54:01

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Link to MarketWatch's Slice.